ASK REDCHAT ANYTHING ABOUT C4 THERAPEUTICS INC.
C4 Therapeutics Inc. (NASDAQ: CCCC)
Listen to this Section
$3.85
-0.3250
(
-7.79% )
1.2M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| CFT7455DetailsBlood disorder, Hematologic malignancies, Blood cancer, Non-Hodgkin lymphoma, Multiple myeloma |
Phase 1/2 |
| CFT1946DetailsCancer, Solid tumor/s |
Phase 1/2 |
| CFT8919 (EGFR)DetailsCancer, Non-small cell lung carcinoma, Solid tumor/s |
Phase 1 |
| CFT8634 (BiDAC)DetailsRare diseases, Cancer |
Failed |
| Cemsidomide (CFT7455) +/- dexamethasoneDetailsHematologic malignancies, Blood disorder, Non-Hodgkin lymphoma, Blood cancer, Multiple myeloma |
Phase 1/2 |
| CFT8919 (EGFR)DetailsSolid tumor/s, Non-small cell lung carcinoma, Cancer |
Phase 1 |
Market Data
|
| Open |
$3.85 |
| Previous Close |
$4.17 |
| Volume |
1.2M |
| Market Cap |
$437.85M |
| Day Range |
$3.84 - $4.28 |
| 52 Week Range |
$1.36 - $4.60 |
| Shares Outstanding |
110.57M |
| Change % |
-7.79% |
| Net Change |
▼ -0.3250 |
| Insider Ownership |
-0.03% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,005,848.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-11 |
Sale |
-6191.00 |
REYNO LEONARD |
| 2024-07-02 |
Sale |
-2320.00 |
Anderson Kenneth Carl |
| 2024-07-02 |
Sale |
-2836.00 |
GROGAN DONNA ROY |
| 2024-06-21 |
Sale |
-32500.00 |
Koppikar Utpal |
| 2024-06-21 |
Sale |
-32500.00 |
Bessen Laura |
| 2024-06-21 |
Sale |
-32500.00 |
Hughes Owen |
| 2024-06-21 |
Sale |
-32500.00 |
DOWNEY BRUCE |
| 2024-06-21 |
Sale |
-32500.00 |
Salter Malcolm |
| 2024-06-21 |
Sale |
-32500.00 |
Anderson Kenneth Carl |
| 2024-06-21 |
Sale |
-32500.00 |
GROGAN DONNA ROY |